Literature DB >> 18177348

Regulation of melanogenesis--controversies and new concepts.

Karin U Schallreuter1, Sonal Kothari, Bhaven Chavan, Jennifer D Spencer.   

Abstract

Despite many efforts, regulation of skin and hair pigmentation is still not fully understood. This article focuses mainly on controversial aspects in pigment cell biology which have emerged over the last decade. The central role of tyrosinase as the key enzyme in initiation of melanogenesis has been closely associated with the 6BH4 dependent phenylalanine hydroxylase (PAH) and tyrosine hydroxylase isoform I (THI) providing evidence for an old concept of the three enzyme theory in the initiation of the pigmentation process. In this context, it is noteworthy that intracellular L-phenylalanine uptake and turnover to L-tyrosine via PAH is vital for substrate supply of THI and tyrosinase. While PAH acts in the cytosol of melanocytes, THI and tyrosinase are sitting side by side in the melanosomal membrane. THI at low pH provides L-3,4-hydroxyphenylalanine L-DOPA which in turn is required for activation of met-tyrosinase. After an intramelanosomal pH change, possibly by the p-protein, has taken place, tyrosinase is subject to control by 6/7BH4 and the proopiomelanocortin (POMC) peptides alpha-MSH melanocyte stimulating hormone and beta-MSH in a receptor independent manner. cAMP is required for the activation of microphthalmia-associated transcription factor to induce expression of tyrosinase, for transcription of THI and for activation of PAH. The redundancy of the cAMP signal is discussed. Finally, we propose a novel mechanism involving H2O2 in the regulation of tyrosinase via p53 through transcription of hepatocyte nuclear factor 1alpha which in turn can also affect the POMC response.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18177348     DOI: 10.1111/j.1600-0625.2007.00675.x

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  83 in total

Review 1.  L-tyrosine and L-dihydroxyphenylalanine as hormone-like regulators of melanocyte functions.

Authors:  Andrzej Slominski; Michal A Zmijewski; John Pawelek
Journal:  Pigment Cell Melanoma Res       Date:  2011-09-02       Impact factor: 4.693

Review 2.  Current position of TNF-α in melanomagenesis.

Authors:  Iuliana Nenu; Diana Tudor; Adriana Gabriela Filip; Ioana Baldea
Journal:  Tumour Biol       Date:  2015-08-18

3.  The melanosomal protein PMEL17 as a target for antibody drug conjugate therapy in melanoma.

Authors:  Youjun Chen; Cecile Chalouni; Christine Tan; Robyn Clark; Rayna Venook; Rachana Ohri; Helga Raab; Ron Firestein; William Mallet; Paul Polakis
Journal:  J Biol Chem       Date:  2012-05-21       Impact factor: 5.157

Review 4.  Comparative genomics of trace element dependence in biology.

Authors:  Yan Zhang; Vadim N Gladyshev
Journal:  J Biol Chem       Date:  2011-05-12       Impact factor: 5.157

5.  cAMP-dependent activation of protein kinase A as a therapeutic target of skin hyperpigmentation by diphenylmethylene hydrazinecarbothioamide.

Authors:  Hyoeun Shin; Seung Deok Hong; Eunmiri Roh; Sang-Hun Jung; Won-Jea Cho; Sun Hong Park; Da Young Yoon; Seon Mi Ko; Bang Yeon Hwang; Jin Tae Hong; Tae-Young Heo; Sang-Bae Han; Youngsoo Kim
Journal:  Br J Pharmacol       Date:  2015-04-24       Impact factor: 8.739

6.  The role of melanin pigment in melanoma.

Authors:  Radomir M Slominski; Michal A Zmijewski; Andrzej T Slominski
Journal:  Exp Dermatol       Date:  2015-04       Impact factor: 3.960

7.  Coat color determination by miR-137 mediated down-regulation of microphthalmia-associated transcription factor in a mouse model.

Authors:  Changsheng Dong; Haidong Wang; Linli Xue; Yanjun Dong; Lei Yang; Ruiwen Fan; Xiuju Yu; Xue Tian; Shuhui Ma; George W Smith
Journal:  RNA       Date:  2012-07-30       Impact factor: 4.942

8.  Targeting ALDH1A1 to treat pigmentary disorders.

Authors:  Konrad Kleszczynski; Andrzej T Slominski
Journal:  Exp Dermatol       Date:  2013-05       Impact factor: 3.960

9.  Evaluation of depigmenting activity by 8-hydroxydaidzein in mouse B16 melanoma cells and human volunteers.

Authors:  Sorgan Shou-Ku Tai; Ching-Gong Lin; Mon-Han Wu; Te-Sheng Chang
Journal:  Int J Mol Sci       Date:  2009-11-20       Impact factor: 6.208

Review 10.  An updated review of tyrosinase inhibitors.

Authors:  Te-Sheng Chang
Journal:  Int J Mol Sci       Date:  2009-05-26       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.